0.057 USD
-0.07 (-55.98%)
0.0399 USD
-0.02 (-30%)
ChartMill assigns a Buy % Consensus number of 83% to CDAK. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 9.18. This target is 16005.26% above the current price.
- CDAK was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CDAK.
- In the previous month the buy percentage consensus was at a similar level.
- CDAK was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-07 | Goldman Sachs | Maintains | Neutral |
| 2022-09-01 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2022-07-05 | Goldman Sachs | Maintains | Buy |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-02-22 | Wedbush | Maintains | Outperform |
| 2022-02-11 | Goldman Sachs | Initiate | Buy |
CODIAK BIOSCIENCES INC / CDAK FAQ
What is the average price target for CODIAK BIOSCIENCES INC (CDAK) stock?
7 analysts have analysed CDAK and the average price target is 9.18 USD. This implies a price increase of 16005.26% is expected in the next year compared to the current price of 0.057.
What is the consensus rating for CDAK stock?
The consensus rating for CODIAK BIOSCIENCES INC (CDAK) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover CODIAK BIOSCIENCES INC (CDAK) stock?
The number of analysts covering CODIAK BIOSCIENCES INC (CDAK) is 7.